Tech Company Financing Transactions
Revelation Biosciences Funding Round
On 1/7/2021, Revelation Biosciences landed $9.1 million in Series A funding from Global Health Investment Fund and private investors.
Transaction Overview
Company Name
Announced On
1/7/2021
Transaction Type
Venture Equity
Amount
$9,100,000
Round
Series A
Investors
Global Health Investment Fund (Lead Investor)
Proceeds Purpose
The company intends to use the net proceeds for general working capital purposes and the development of REVTx-99 and REVDx-501.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
350 Sharon Park Dr. R4
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Revelation Biosciences, Inc. is a clinical stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. The Company has several product candidates in development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Rolke
Chief Financial Officer
Chester Zygmont
Vice President
Robin Marsden
VP - Human Resources
Sandra Vedrick
Browse more venture capital transactions:
Prev: 1/7/2021: Boston Metal venture capital transaction
Next: 1/7/2021: Senti Biosciences venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs